Announcement

Collapse
No announcement yet.

Summary of Information on Changing from Vetsulin to NPH

Collapse
This topic is closed.
X
This is a sticky topic.
X
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • #16
    Vetsulin - FDA Warning - AAHA Protocol for Change to NPH

    I just finished listening to the web conference on changing insulins. Most of it was about what I expected and what we have talked about here.

    Dr. Nelson addressed dogs and his feeling was that NPH is readily available, has a similar duration and action as Vetsulin, and has decades of successful use so it makes sense for that to be the insulin to switch to.

    [NOTE: The following was stated BEFORE Intervet released a second letter on November 30 strongly stressing that all patients should be switched to a different insulin product because of anticipated supply shortages, which are already starting to show up in the third week of January.]He does not recommend switching if your dog is doing really really well on Vetsulin, at least until lack of supply makes it necessary if it comes to that.

    He has not had much success with either Lantus or Detemir but he also makes note that he doesn't see dogs who are just starting insulin. He only sees dogs who are having problems so that may skew his results.

    He said he has sometimes had success using Detemir in combination with Regular insulin as the response to the Detemir was apparently a pretty flat basal type response. But he says he doesn't like having to use two insulins at the same time because it decreases owners' willingness to keep up the treatment.

    His goal for a well regulated dog is blood sugar mostly between 80 and 300 with an average for the day of 250 or less.

    His recommendation for a starting dose when switching to NPH is to cut the dose "a few units" - from the examples he gave, he would reduce the dose about 20%, for all the reasons we have discussed... the insulin action may be different so best to start on the low end and work up.

    One interesting new insulin is the new PZI - ProZinc.

    The old PZI was not recommended for dogs because it contained mostly beef-derived insulin and generated a lot of resistance in dogs. That insulin is being discontinued and ProZinc is just being released. It is human-type insulin, like NPH and Lantus.

    It remains to be seen how dogs will do on it. Generally, if the insulin action is slowed down too much, dogs haven't gotten a very good response. Ultralente was another long-acting insulin that, used by itself, generally did not work well. So it's hard to say if PZI, now that it's human insulin, which usually works well with dogs, will have a good effect in the protamine zinc formulation.

    Natalie

    Comment


    • #17
      Re: Vetsulin - FDA Warning - AAHA Protocol for Change to NPH

      I heard from a member today who said she got an email from 1-800-PetMeds that Vetsulin will not be available from them 3-4 weeks from now.

      Natalie

      Comment


      • #18
        Re: Vetsulin - FDA Warning - AAHA Protocol for Change to NPH

        Thank you Eileen for bringing the newest Intervet letter regarding supplies of Vetsulin to our attention!

        January 8, 2010

        Re: Transition Assistance Via Independent Phone Consultation

        Dear Doctor:

        We appreciate all your efforts in transitioning your diabetic patients currently on Vetsulin® (porcine insulin zinc suspension) to other insulin products. As discussed in our letter dated November 30, 2009, it is imperative that you transition all of your diabetic patients off of Vetsulin as future supplies of Vetsulin will be very limited in early 2010, and then exhausted.

        Intervet/Schering-Plough Animal Health has worked with expert members of the AAHA Diabetes Guidelines Task Force and provided information on transitioning dogs and cats from Vetsulin to other insulin products (see links to these documents below). However, we have received calls from some concerned veterinarians who are still encountering difficulties despite having followed these recommendations. Therefore, we would like to offer assistance to two specific categories:
        1. Where there are still difficulties in re-regulating patients on other insulin products;
        2. Where a veterinarian had initially prescribed Vetsulin because other insulin products had been ineffective in regulating their patient.
        In order to assist with these specific patient categories, Intervet/Schering-Plough Animal Health has contracted with Thomas K.Graves, DVM, PhD, DACVIM and his staff at the University of Illinois, College of Veterinary Medicine, to provide independent telephone consultations on these difficult cases.

        Please note that Intervet/Schering-Plough Animal Health is making this service available as a patient courtesy. Dr. Graves will be acting as an independent consulting veterinarian, and Intervet/Schering-Plough Animal Health does not guarantee or warrant that the consultation will lead to a successful resolution of these cases. Intervet/Schering-Plough Animal Health will not bear any responsibility for the outcomes of these cases.

        If you have a patient that falls into either of the two categories mentioned above, please contact Intervet/Schering-Plough Animal Health technical services at 1-800-224-5318 to discuss if the case qualifies for a telephone consultation with either Dr. Graves or one of his board certified internists.

        The costs associated with the telephone consultations organized by our technical services veterinarians will be covered by Intervet/Schering-Plough Animal Health. Any cost incurred as a result of the consultation, including, but not limited to, additional veterinary fees, recommended additional diagnostic tests or additional medications, will not be covered by this program.

        Thank you for your cooperation and efforts to transition diabetic patients off of Vetsulin and onto other insulin products.

        Sincerely,

        Christopher Pappas, Jr., DVM
        Director, Companion Animal Technical Services
        Intervet/Schering-Plough Animal Health
        http://vetsulin.com/vet/Vet_ProductAlert.aspx

        Comment


        • #19
          Vetsulin Sales Prohibited - FDA Warning - Dogs Changing to NPH

          This announcement was made yesterday (5/5/2010) by the fda. Thought it may be of interest to some.

          http://tinyurl.com/24gq3ef

          FDA Announces Availability of Vetsulin for Critical Needs Dogs and Cats
          May 5, 2010

          The Food and Drug Administration (FDA) announced today a plan to address concerns regarding the supply of Intervet/Schering Plough Animal Health’s (Intervet) Vetsulin (porcine insulin zinc suspension), a product used to treat diabetes in dogs and cats. FDA is allowing Intervet to offer a limited supply of Vetsulin through their Vetsulin Critical-Need Program. The supply is only to be used for a critical-need dog or cat that, in the medical judgment of the pet’s veterinarian, cannot be effectively managed on another insulin product.

          In November 2009, FDA announced its concerns about the stability of Vetsulin and recommended that diabetic dogs and cats currently receiving Vetsulin be switched to other insulin products. After publicizing this recommendation, FDA and Intervet heard from many veterinarians and pet owners who expressed significant concerns about specific diabetic dogs and cats which could only be controlled with Vetsulin.

          As a result of these concerns, FDA is recommending veterinarians with qualified patients contact Intervet’s Technical Services Department at 800-224-5318, to request enrollment of the patient in the Vetsulin Critical-Need Program. The veterinarian will need to provide the medical rationale for why the patient cannot be effectively controlled using another insulin product.

          Intervet continues to work with FDA to address concerns associated with the manufacture of Vetsulin. Because Vetsulin may have varying amounts of crystalline zinc insulin in the formulation, it could cause a delay in insulin action and an overall longer duration of insulin activity. Insulin products that do not remain within specification throughout the entire shelf life could potentially result in unpredictable fluctuations in the glucose levels of diabetic patients.

          Use of this product under the Critical-Need Program will require close monitoring of the patient, all of which is described in an owner consent form.
          Eileen/Mildred

          Eileen and Mildred, 12 yo Border Collie Mx, 24.6 pounds, dx diabetic/hypothyroid 2004, gallbladder removed 2005, cataract surgery 2005, spindle cell sarcoma removed 2009, stroke 2009, tail removed 2011, dx with bladder cancer 2011, CDS, Organix~chicken / NPH,Humalog

          Comment


          • #20
            Re: Vetsulin Sales Prohibited - FDA Warning - Dogs Changing to NPH

            Web seminar on changing dogs and cats from Vetsulin, with dogs recommended changed to NPH:

            http://www.aahanet.org/education/wc_vetsulinupdate.aspx

            Comment


            • #21
              Re: Vetsulin Sales Prohibited - Summary of Information on Changing to NPH

              The complete set of letters addressed to veterinarians is located at:

              http://www.vetsulin.com/vet/Vet_ProductAlert.aspx

              These are what should be printed for your veterinarian when addressing this issue.

              Comment


              • #22
                Re: Vetsulin Sales Prohibited - Summary of Information on Changing to NPH

                With Vetsulin returning to the U.S. market as of April 2013, I thought it would be good to bring this thread back up as far as how to change to a new insulin. Following are notes I pulled from Dr. Richard Nelson's webinar about how to switch a dog from Vetsulin to NPH. The same process applies when switching in the opposite direction.

                I just finished listening to the web conference on changing insulins. Most of it was about what I expected and what we have talked about here.

                Dr. Nelson addressed dogs and his feeling was that NPH is readily available, has a similar duration and action as Vetsulin, and has decades of successful use so it makes sense for that to be the insulin to switch to.

                He said he has sometimes had success using Detemir in combination with Regular insulin as the response to the Detemir was apparently a pretty flat basal type response. But he says he doesn't like having to use two insulins at the same time because it decreases owners' willingness to keep up the treatment.

                His goal for a well regulated dog is blood sugar mostly between 80 and 300 with an average for the day of 250 or less.

                His recommendation for a starting dose when switching to NPH is to cut the dose "a few units" - from the examples he gave, he would reduce the dose about 20%, for all the reasons we have discussed... the insulin action may be different so best to start on the low end and work up.

                Natalie
                As we went through the switchover a couple of years ago from Vetsulin to NPH, we found that cutting the dose 20-25% generally worked well.

                That assumes that the insulin you're switching from works well. If your dog is not responding much to the current insulin, then the goal of switching is finding an insulin that works better and you could need significantly less units of insulin per injection in that case. For those dogs, I suggest "starting over" with the recommended dose per weight of 1/5 to 1/4 unit per pound (assuming causes resistance to the effect of any insulin have been ruled out).

                Natalie

                Comment

                Working...
                X